Webinar: The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study

9 Jul 2020

Time: Tuesday, July 9, 2020 5:00 PM – 6:30 PM CET


– Anand Anandkumar, Co-founder and CEO Bugworks Research Inc (India)

– Kamini Walia, Program Officer, ICMR-AMR Initiative (India)

Moderator: François Franceschi, GARDP

In this webinar, Anand Anandkumar and Kamini Walia will discuss:

– Why is India one of the hotbeds of the AMR problem? Latest statistics of growing drug resistance etc.

– Initiatives of the Indian Government to curb the AMR problem

– Antimicrobial R&D landscape in India – a vibrant ecosystem supporting innovation in AMR diagnosis, prevention and therapeutics

– Fledgling antimicrobial clinical trial networks – could trials out of India play a significant role in gaining global regulatory approvals?

– Changing regulatory environment to enable accelerated approvals for antimicrobial products

The presentation will be followed by a Q&A session.

Register now for this live webinar including interactive Q&A session on July 9 2020, 17:00-18:30 CET (find your time zone here).

If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us by email: revive@gardp.org.


We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.